PerkinElmer Aktie
| 111,11USD | -0,25USD | -0,22% |
WKN: 850943 / ISIN: US7140461093
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99,62 |
| T. Rowe Price Investment Management, Inc. | 14,43 |
| T. Rowe Price Investment Management, Inc. | 14,43 |
| The Vanguard Group, Inc. | 11,49 |
| Vanguard Group, Inc. (Subfiler) | 11,02 |
| T Rowe Price Capital Appreciation Fund | 9,34 |
| T. Rowe Price Associates, Inc. (IM) | 5,25 |
| Janus Henderson Investors US LLC | 5,14 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 5,11 |
| Janus Henderson Investors US LLC | 4,84 |
| State Street Corp. | 4,20 |
| Select Equity Group LP | 4,20 |
| Select Equity Group LP | 4,20 |
| Janus Henderson Enterprise Fund | 3,59 |
| Vanguard Total Stock Market ETF | 3,16 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 13 000 | 14 000 | 16 700 | 16 700 | 11 500 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,22 | 0,27 | 0,30 | 0,20 | 0,24 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 374 | 2 239 | 2 441 | 3 289 | 3 001 |
| Summe Anlagevermögen | 5 164 | 5 721 | 12 560 | 10 841 | 10 564 |
| Summe Aktiva | 6 539 | 7 960 | 15 001 | 14 130 | 13 565 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 2 257 | 2 219 | 5 210 | 4 595 | 4 065 |
| Summe Fremdkapital | 3 725 | 4 225 | 7 859 | 6 747 | 5 692 |
| Summe Eigenkapital | 2 814 | 3 735 | 7 141 | 7 383 | 7 873 |
| Summe Passiva | 6 539 | 7 960 | 15 001 | 14 130 | 13 565 |
Adresse
| 77 Citypoint 4th Avenue, 02451 Waltham | |
| Telefon | +1 (877) 373-6374 |
| Internet | http://www.revvity.com |
Management
|
Alexis Platon Michas
Non-Executive Chairman |
|
Anita Gonzales
Vice President & Controller |
|
Arvind Sundar Rajan
Vice President-Digital & Technology |
|
Bryan A. Kipp
VP & General Manager-Life Sciences Integration |
|
Daniel R. Tereau
Senior VP-Strategy & Business Development |
|
Franklin R. Witney
Independent Director |
|
Jayashree Kailas Thacker
Chief Information Officer & Senior Vice President |
|
Joel S. Goldberg
Secretary, SVP-Administration & General Counsel |
|
Madhuri Hegde
Chief Scientific Officer & Senior Vice President |
|
Magali Four
Chief People & Culture Officer & SVP |
|
Maxwell Krakowiak
Chief Financial Officer & Senior Vice President |
|
Michael Klobuchar
Independent Director |
|
Michel Pericles Vounatsos
Independent Director |
|
Michelle McMurry-Heath
Independent Director |
|
Miriame Victor
Chief Commercial Officer & Senior Vice President |
|
Pascale Witz
Independent Director |
|
Peter Barrett
Independent Director |
|
Prahlad Ramadhar Singh
President, Chief Executive Officer & Director |
|
Samuel Ross Chapin
Independent Director |
|
Sophie V. Vandebroek
Independent Director |
|
Steve Willoughby
Vice President-Investor Relations |
|
Tajinder S. Vohra
Senior Vice President-Global Operations |
|
Yi Ping Lin
Chief Quality, Regulatory & Clinical Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
